The Cigna Group — Form 8-K Summary
Business context and reporting period
Filed September 30, 2026, under Item 7.01, this current report provides Regulation FD disclosure about Cigna’s Investor Day and expected reaffirmation of its full-year 2026 outlook. It is not a quarterly or annual financial-results filing and reports no period-specific operating results.
Outlook and key financial metrics
- 2026 consolidated adjusted revenues: approximately $280 billion.
- 2026 consolidated adjusted earnings per share: at least $30.45.
- Evernorth Health Services 2026 adjusted income from operations: at least $6.9 billion.
- Cigna Healthcare 2026 adjusted income from operations: at least $4.55 billion.
- Cigna Healthcare 2026 medical care ratio: 83.7%–84.7%.
- Long-term average annual adjusted EPS growth target: 10%–14%.
The filing does not provide current revenue, profit, cash flow, margin, debt, or liquidity results, or comparable-period actuals.
Changes versus prior outlook
Management said it expects to reaffirm the 2026 outlook previously discussed in a July 30, 2026 press release and conference call. This filing does not identify a change to that outlook or provide a prior-period comparison.
Management commentary, risks, and contingencies
The outlook includes anticipated 2026 dividends and expected future share repurchases, but excludes potential business combinations occurring after the report date. Dividend declarations remain subject to board approval; the timing and number of share repurchases depend on market conditions, share price, and other capital uses, and the program may be suspended or discontinued.
Adjusted revenues, adjusted income from operations, and adjusted EPS are non-GAAP measures. Cigna says it cannot reconcile forward-looking adjusted income from operations or adjusted revenues to the corresponding GAAP measures without unreasonable effort, citing uncertainty around future investment results and special items. Actual results may differ materially due to risks including medical-cost trends and claims estimates, pricing and pharmacy-market changes, regulation, litigation, cybersecurity, third-party relationships, strategic transactions, economic conditions, and indebtedness.
Important facts for investors to verify
- Whether management formally reaffirms or changes the 2026 outlook at Investor Day and in subsequent investor meetings.
- Definitions and any historical GAAP reconciliations for the non-GAAP measures in the Investor Day materials.
- Actual medical-cost experience relative to the projected medical care ratio range.
- Capital deployment assumptions, including planned repurchases and dividends, and any changes to them.